Drugs / Sucrosomial Iron
Sucrosomial Iron
Trials 9
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT04587141 | Jan 2020 → Jun 2023 | inflammatory bowel disease, iron deficiency anemia | Fondazione IRCCS Policlinico San Matteo di Pavia | Unknown | No outcome recorded |
| Phase 3 | NCT05225545 | Nov 2019 → May 2024 | iron deficiency anemia, ulcerative colitis | American University of Beirut Medical Center | Unknown | No outcome recorded |
| Phase 44 trials | ||||||
| Phase 4 | NCT07287371 | Dec 2026 → Jun 2027 | iron deficiency anemia | University of Rochester | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT07308769 | Dec 2025 → Oct 2026 expected | iron deficiency anemia | Pharmanutra S.p.a. | Recruiting | No outcome recorded |
| Phase 4 | NCT07038330 | Jun → Oct 2025 overdue | anemia | Cardiochirurgia E.H. | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT05702970 | Jan 2024 → Apr 2025 | disorder of iron metabolism and transport, mild heart failure, moderate heart failure, systolic heart failure +1 | University of Padova | Unknown | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT07163390 | Sep 2025 → Jul 2027 expected | iron deficiency anemia | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Not yet recruiting | No outcome recorded |
| — | NCT05678647 | Jan 2023 → Mar 2026 | — | Uppsala University Hospital | Completed | No outcome recorded |
| — | NCT03560687 | Oct 2018 → May 2020 | anemia | Cardiochirurgia E.H. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03833336 Comparator | Aug 2017 → Sep 2024 | diastolic heart failure, iron deficiency anemia | Institut de Recerca Biomèdica de Lleida | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 6
| Date | Issuer | Release |
|---|---|---|
| 2018-12-10 | Pharmanutra S.p.a. | Results Riconosciuti nuovi ambiti di applicazione per il Ferro Sucrosomiale pharmanutra.it ↗
Inoltre, si è evidenziato come i soggetti abbiano mostrato un miglioramento del decorso della malattia intestinale nel periodo di osservazione. |
| 2016-12-14 | Pharmanutra S.p.a. | Results Sideral Forte al 58th ASH Annual Meeting & Exposition: l’evento dell’anno di rilevanza mondiale in campo ematologico pharmanutra.it ↗
Quest’anno siamo stati chiamati a presentare le recenti evidenze scientifiche sul nostro ferro sucrosomiale® e abbiamo avuto così la possibilità di parlarne al più importante congresso di ematologia al Mondo |
| 2015-12-10 | Pharmanutra S.p.a. | Results Due studi sul SiderAL® pubblicati sul Blood Journal pharmanutra.it ↗
Lo studio di biodisponibilità, mostra la maggiore biodisponibilità del Sideral® rispetto al Ferro solfato e ad altre formulazioni di ferro contenenti lecitina. |
| 2014-10-08 | Pharmanutra S.p.a. | Results Nuovo studio sul Sideral Forte al Congresso SIN a Catania pharmanutra.it ↗
I risultati dello studio dimostrano come Sideral Forte sia in grado di incrementare i valori di Hb e ridurre i marcatori di infiammazione coma la Proteina C Reattiva (PRC), diminuendo significativamente il consumo settimanale di Epoetina (EPO) di circa 2000 UI/settimana. |
| 2014-08-07 | Pharmanutra S.p.a. | Results SiderAL Forte® al prossimo congresso dell’European Iron Club di Verona – Meeting 2014 pharmanutra.it ↗
Liposomial iron has an anti-inflammatory effect and is better than iron sulfate in correction of anemia of chronic inflammatory disease of young women. |
| 2013-11-25 | Pharmanutra S.p.a. | Results Gli ultimi studi clinici: una panoramica pharmanutra.it ↗
E al contempo è in grado di innalzare l’emoglobina. |
All press releases naming this drug 18 releases
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sucrosomial Iron | “They start oral supplementation with Sucrosomial iron® 30 mg (Sideral® Folico), 2 sticks for twice a day for 15 days, followed by Sucrosomial iron ® 30 mg (Sideral® Folico), 1...” NCT07163390 ↗9“Sucrosomial® Iron (Sideral® Forte), 30 mg elemental iron per capsule” NCT07308769 ↗ |
| Known as | Sideral Folico | “They start oral supplementation with Sucrosomial iron® 30 mg (Sideral® Folico), 2 sticks for twice a day for 15 days, followed by Sucrosomial iron ® 30 mg (Sideral® Folico), 1...” NCT07163390 ↗ |
| Known as | Sideral Forte | “Sucrosomial® Iron (Sideral® Forte), 30 mg elemental iron per capsule” NCT07308769 ↗ |
| Route | Oral | “received either a one-month course of sucrosomial iron (60 mg/day) or no treatment prior to elective heart surgery at a single high-volume centre” PMID 34710946 ↗ Oct 2021 |